As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access.
This webinar covers patient navigation touchpoints along the PrEP continuum for injectable lenacapavir, patient education strategies, expanding the capacity of PrEP navigation staff to implement injectable PrEP, and future opportunities for expanded implementation in mobile health settings.
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.
LGBTQ Equity in HIV Prevention and Treatment Series, Module 5 of 5.
Join Aniruddha Hazra, MD, as he examines the intersection of aging, HIV, and broader health needs for older gay and bisexual men, with a focus on care coordination and long-term wellness. Additionally, Dr. Hazra will also provide critical insights into managing comorbidities, addressing social and mental health challenges, and strengthening interdisciplinary approaches to ensure holistic, affirming care for aging gay and bisexual men living with or at risk for HIV.
LGBTQ Equity in HIV Prevention and Treatment Series, Module 4 of 5.
Join Asa Radix, MD, PhD, MPH, as they explore best practices in delivering gender-affirming, patient-centered HIV prevention and treatment. Additionally, Dr. Radix will also provide critical insights into reducing barriers to care, integrating inclusive clinical practices, and addressing the unique health needs of transgender and gender diverse communities across the HIV care continuum.
LGBTQ Equity in HIV Prevention and Treatment Series, Module 3 of 5.
This module explores the intersection of identity, stigma, and structural barriers that impact HIV prevention and care for same-gender-loving (SGL) Black and Latino men.
LGBTQ Equity in HIV Prevention and Treatment Series, Module 2 of 5.
This activity examines the structural and systemic barriers LGBTQ individuals face when accessing HIV prevention and care services. Participants will review evidence-based strategies for improving access, such as navigation support, inclusive care models, and approaches to address stigma, documentation, and insurance-related challenges.
LGBTQ Equity in HIV Prevention and Treatment Series, Module 1 of 5.
This activity provides an overview of current HIV prevention and treatment options with a focus on tailoring care to the needs and preferences of LGBTQ individuals. Participants will explore patient-centered approaches to sexual history-taking, age-specific care considerations, and integration of STI prevention strategies, including DoxyPEP, into comprehensive HIV prevention planning.
Dr. Demetre Daskalakis, CDC’s Director of the Division of HIV Prevention, delves into these clinical guidelines and reviews the latest PrEP science. Following his presentation, Dr. Anu Hazra will speak to the clinical considerations of the guidelines from a PrEP provider standpoint.
This interactive webinar featured the perspectives of multiple diverse HIV prevention experts on PrEP uptake among relevant consumer/patient communities, including Black women, same-gender-loving (SGL) Black and Latino men, and transgender individuals.